DE69027262D1 - 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase - Google Patents

4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase

Info

Publication number
DE69027262D1
DE69027262D1 DE69027262T DE69027262T DE69027262D1 DE 69027262 D1 DE69027262 D1 DE 69027262D1 DE 69027262 T DE69027262 T DE 69027262T DE 69027262 T DE69027262 T DE 69027262T DE 69027262 D1 DE69027262 D1 DE 69027262D1
Authority
DE
Germany
Prior art keywords
beta
androst
cyclopropyloxy
substituted
lyase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69027262T
Other languages
English (en)
Other versions
DE69027262T2 (de
Inventor
Michael R Angelastro
Thomas R Blohm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of DE69027262D1 publication Critical patent/DE69027262D1/de
Application granted granted Critical
Publication of DE69027262T2 publication Critical patent/DE69027262T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0018—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022—Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0029—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003—Androstane derivatives
    • C07J1/0033—Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/0037—Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being a saturated hydrocarbon group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69027262T 1989-08-15 1990-08-10 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase Expired - Fee Related DE69027262T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/394,026 US4966897A (en) 1989-08-15 1989-08-15 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Publications (2)

Publication Number Publication Date
DE69027262D1 true DE69027262D1 (de) 1996-07-11
DE69027262T2 DE69027262T2 (de) 1996-10-02

Family

ID=23557245

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69027262T Expired - Fee Related DE69027262T2 (de) 1989-08-15 1990-08-10 4-Substitutiertes 17-beta-(Cyclopropyloxy)androst-5-en-3-beta-ol und seine Derivate, verwendbar als Inhibitoren der C17-20-Lyase

Country Status (22)

Country Link
US (1) US4966897A (de)
EP (1) EP0413269B1 (de)
JP (1) JP2879702B2 (de)
KR (1) KR910004650A (de)
CN (1) CN1050195A (de)
AT (1) ATE138930T1 (de)
AU (1) AU628210B2 (de)
CA (1) CA2023008C (de)
DD (1) DD298106A5 (de)
DE (1) DE69027262T2 (de)
DK (1) DK0413269T3 (de)
ES (1) ES2090064T3 (de)
FI (1) FI95711C (de)
GR (1) GR3020797T3 (de)
HU (1) HUT55030A (de)
IE (1) IE902941A1 (de)
IL (1) IL95359A (de)
NO (1) NO903565L (de)
NZ (1) NZ234855A (de)
PH (1) PH27549A (de)
PT (1) PT94994B (de)
ZA (1) ZA906307B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
JP3546886B2 (ja) * 1993-03-10 2004-07-28 ジェネーラ コーポレーション ステロイド誘導体、それらを含む薬剤組成物、及び抗生物質又は消毒薬としてのそれらの使用
US5486511A (en) * 1993-05-25 1996-01-23 Merrell Dow Pharmaceuticals Inc. 4-amino-17β-(cyclopropyloxy)androst-4-en-3-one, 4-amino-17β-(cyclopropylamino)androst-4-en-3-one and related compounds as C17-20 lyase and 5α-reductase
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5840740A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds and a method of treating infection using the aminosterol compounds
US5856535A (en) * 1994-08-18 1999-01-05 Magainin Pharmaceuticals, Inc. Aminosterol ester compounds
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5661141A (en) * 1995-03-27 1997-08-26 Petrow; Vladimir 19-oxygenated steroids as therapeutic agents
US5795885A (en) * 1995-06-07 1998-08-18 Magainin Pharmaceuticals Inc. Method of inhibiting profileration of cells by administering an aminosterol compound
US5763430A (en) * 1995-06-07 1998-06-09 Magainin Pharmaceuticals Inc. Method of treating a viral infection by administering a steroid compound
US5874597A (en) * 1995-06-07 1999-02-23 Magainin Pharmaceuticals, Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5840936A (en) * 1995-06-07 1998-11-24 Magainin Pharmaceuticals Inc. Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE)
US6143738A (en) * 1995-06-07 2000-11-07 Magainin Pharmaceuticals, Inc. Therapeutic uses for an aminosterol compound
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
US5847172A (en) * 1995-06-07 1998-12-08 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and pharmaceutical compositions including these compounds
US5994336A (en) * 1995-06-07 1999-11-30 Magainin Pharmaceuticals Inc. Method of inhibiting proliferation of cells by administering an aminosterol compound
US6365597B1 (en) 1996-02-14 2002-04-02 Aventis Pharmaceuticals Inc. 4-aza steroids
DK0910382T3 (da) * 1996-04-26 2003-10-06 Genaera Corp Squalamin i kombination med andre anticancermidler til behandling af tumorer
US6596712B2 (en) 1996-04-26 2003-07-22 Genaera Corporation Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
US6262283B1 (en) 1996-12-06 2001-07-17 Magainin Pharmaceuticals Inc. Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
CA2406847C (en) * 2000-04-12 2009-11-17 Genaera Corporation Regioselective and stereoselective oxidation of fused ring systems useful for the preparation of aminosterols
JP2007297879A (ja) * 2006-05-02 2007-11-15 Central Glass Co Ltd 電磁波吸収板

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3475464A (en) * 1966-11-07 1969-10-28 Syntex Corp Process for the preparation of steroids and novel intermediates thereof
US4139617A (en) * 1974-05-13 1979-02-13 Richardson-Merrell Inc. 19-Oxygenated-androst-5-enes for the enhancement of libido
US4891367A (en) * 1987-04-22 1990-01-02 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US4966898A (en) * 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropylamino)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors

Also Published As

Publication number Publication date
NO903565L (no) 1991-02-18
IL95359A0 (en) 1991-06-30
ZA906307B (en) 1991-06-26
DK0413269T3 (da) 1996-06-24
ES2090064T3 (es) 1996-10-16
GR3020797T3 (en) 1996-11-30
HUT55030A (en) 1991-04-29
IE902941A1 (en) 1991-02-27
CA2023008A1 (en) 1991-02-16
IL95359A (en) 1995-08-31
CN1050195A (zh) 1991-03-27
DD298106A5 (de) 1992-02-06
HU905005D0 (en) 1991-01-28
FI904036A0 (fi) 1990-08-15
PT94994B (pt) 1997-05-28
JP2879702B2 (ja) 1999-04-05
CA2023008C (en) 2001-05-15
FI95711C (fi) 1996-03-11
AU628210B2 (en) 1992-09-10
KR910004650A (ko) 1991-03-29
ATE138930T1 (de) 1996-06-15
NZ234855A (en) 1992-11-25
PT94994A (pt) 1991-04-18
EP0413269A2 (de) 1991-02-20
EP0413269A3 (en) 1992-05-20
AU6087890A (en) 1991-02-21
FI95711B (fi) 1995-11-30
US4966897A (en) 1990-10-30
JPH0383996A (ja) 1991-04-09
PH27549A (en) 1993-08-18
NO903565D0 (no) 1990-08-14
DE69027262T2 (de) 1996-10-02
EP0413269B1 (de) 1996-06-05

Similar Documents

Publication Publication Date Title
ATE138930T1 (de) 4-substitutiertes 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase
ATE137761T1 (de) 4-substituiertes 17-beta-(cyclopropyl-amino)- androst-5-en-3-beta-ol und seine derivate, verwendbar als inhibitoren der c17-20-lyase
KR900700486A (ko) 신규한 벤조피리도 피페리딘, 피페리딜리덴 및 피페라진 화합물, 조성물, 제조방법 및 이용방법
DK0721455T3 (da) Tetrahydropyridin-(eller 4-hydroxypiperidin)alkylazoler med en affinitet for sigma og/eller 5-HT1A-receptorer
PT87294A (pt) Process for the preparation of 17beta-(cyclopropylamino)-androst-5-en-3beta-ol and related compounds useful as c17-20 lyase inhibitors and of pharmaceutical compositions containing the same
DE3872938D1 (de) 17-beta-(cyclopropyloxy)androst-5-en-3-beta-ol-derivate und verwandte verbindungen als c17-20 lyase-inhibitoren.
DE69023939T2 (de) Förderung der Osteogenese durch Verwendung von Vitamin D-Derivaten.
ATE59041T1 (de) Hexahydropyrrolo(2,1-a)isochinolinderivate.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee